Please login to the form below

Not currently logged in

Vertex appoints Ken Horton as chief legal officer

Nancy Wysenski to retire as chief commercial officer

Vertex Pharmaceuticals has appointed Ken Horton to the position of chief legal officer and executive VP.

Reporting to Vertex's chair, president and CEO Dr Jeffrey Leiden, Horton will work closely with the departing chief legal officer and senior VP Ty Howton over the next few months during a transition phase.

Howton is not the only one leaving Vertex, with chief commercial officer Nancy Wyenski set to retire after three years at the company.

During her time at Vertex, she built the company's first commercial team to support the approval and launch of Vertex's first medicines, Incivek (telaprevir) and Kalydeco (ivacaftor).

"Nancy was critical in establishing a talented commercial team that led the successful launch of Vertex's first two medicines and in preparing the company for continued growth in the coming years,” said Dr Leiden.

“After more than 30 years in healthcare, she has chosen to move on to the next chapter of her life, and we wish her all the best in retirement.”

A search for a new chief commercial officer is currently ongoing.

13th June 2012


Featured jobs

Subscribe to our email news alerts


Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...